Evidence map›Paper›PMID 28182265›Full record

ArticleJournal of the American Geriatrics Society2017

Long-term Metformin Therapy and Monitoring for Vitamin B12 Deficiency Among Older Veterans.

Vijaya Kancherla, John L Elliott, Birju B Patel, N Wilson Holland, Theodore M Johnson, Anjali Khakharia, Lawrence S Phillips, Godfrey P Oakley, Camille P Vaughan

Abstract read
In one paragraph

Article in Journal of the American Geriatrics Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Vitamin BIrish journal of medical science · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Vitamin BBiomolecules · 2017
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Vijaya KancherlaDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.
John L ElliottDivision of General Medicine & Geriatrics, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Birju B PatelAtlanta VA Medical Center, Decatur, Georgia.
N Wilson HollandDivision of General Medicine & Geriatrics, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Theodore M JohnsonDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Anjali KhakhariaDivision of General Medicine & Geriatrics, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Lawrence S PhillipsAtlanta VA Medical Center, Decatur, Georgia.
Godfrey P OakleyDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Camille P VaughanDivision of General Medicine & Geriatrics, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Emory University · USAtlanta VA Medical Center · USGeriatric Research Education and Clinical Center · US

Funding

Glycemia Reduction Approaches in Diabetes: A comparative effectiveness studyU01DK098246 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI KRAUSE-STEINRAUF, HEIDI, LACHIN, JOHN M · 2012 to 2022
$238.9M
Vitamin D and Type 2 Diabetes (D2d)U01DK098245 · NIDDK · TUFTS MEDICAL CENTER · PI PITTAS, ANASTASSIOS G · 2013 to 2020
$45.6M
Translational Research Core - Engagement and Behavior ChangeP30DK111024 · NIDDK · EMORY UNIVERSITY · PI Mohammed Kumail Ali · 2016 to 2026
$13.4M
Screening for IGT: Glucose Challenge vs Predictive ModelR18DK066204 · NIDDK · EMORY UNIVERSITY · PI PHILLIPS, LAWRENCE S · 2004 to 2007
$2.9M
Prevention of Cystic Fibrosis DiabetesR01FD003527 · FDA · EMORY UNIVERSITY · PI STECENKO, ARLENE A · 2009 to 2015
$908k
Vitamin D for Type 2 Diabetes (D2D trial)U34DK091958 · NIDDK · TUFTS MEDICAL CENTER · PI PITTAS, ANASTASSIOS G · 2011 to 2012
$792k
Reach, Outcomes and System Impacts of the VA's National Weight Loss Program, MOVER21DK099716 · NIDDK · EMORY UNIVERSITY · PI PHILLIPS, LAWRENCE S · 2014 to 2015
$321k
Behavioral therapy to treat urinary symptoms in Parkinson's diseaseIK2RX000747 · VA · VETERANS HEALTH ADMINISTRATION · PI VAUGHAN, ELIZABETH CAMILLE · 2012 to 2016
–
FDA HHS R01 FD003527NIDDK NIH HHS P30 DK111024NIDDK NIH HHS R18 DK066204NIDDK NIH HHS R21 DK099716NIDDK NIH HHS U01 DK098245NIDDK NIH HHS U01 DK098246NIDDK NIH HHS U34 DK091958RRD VA IK2 RX000747
6 · The paper itself

Abstract

objectiveTo examine the association between long-term metformin therapy and serum vitamin B12 monitoring.

designRetrospective cohort study.

settingA single Veterans Affairs Medical Center (VAMC), 2002-2012.

participantsVeterans 50 years or older with either type 2 diabetes and long-term metformin therapy (n = 3,687) or without diabetes and no prescription for metformin (n = 13,258). MEASUREMENTS: We determined diabetes status from outpatient visits, and defined long-term metformin therapy as a prescription ≥500 mg/d for at least six consecutive months. We estimated the proportion of participants who received a serum B12 test and used multivariable logistic regression, stratified by age, to evaluate the association between metformin use and serum B12 testing.

resultsOnly 37% of older adults with diabetes receiving metformin were tested for vitamin B12 status after long-term metformin prescription. The mean B12 concentration was significantly lower in the metformin-exposed group (439.2 pg/dL) compared to those without diabetes (522.4 pg/dL) (P = .0015). About 7% of persons with diabetes receiving metformin were vitamin B12 deficient (<170 pg/dL) compared to 3% of persons without diabetes or metformin use (P = .0001). Depending on their age, metformin users were two to three times more likely not to receive vitamin B12 testing compared to those without metformin exposure, after adjusting for sex, race and ethnicity, body mass index, and number of years treated at the VAMC.

conclusionLong-term metformin therapy is significantly associated with lower serum vitamin B12 concentration, yet those at risk are often not monitored for B12 deficiency. Because metformin is first line therapy for type 2 diabetes, clinical decision support should be considered to promote serum B12 monitoring among long-term metformin users for timely identification of the potential need for B12 replacement.

Indexed as

Diabetes Mellitus, Type 2FemaleHospitals, VeteransHumansHypoglycemic AgentsMaleMetforminMiddle AgedRetrospective StudiesVeteransVitamin B 12 DeficiencyHypoglycemic AgentsMetforminagingmetformintype 2 diabetesveteransvitamin B12

Identifiers

PMID28182265
PMCPMC5435502
OpenAlexW2587685822

What OpenQuestion holds

Texttitle and abstract
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.